Literature DB >> 8552404

Allelic deletion mapping on chromosome 5 in human carcinomas.

I Wieland1, M Böhm, K C Arden, T Ammermüller, S Bogatz, C S Viars, M F Rajewsky.   

Abstract

We analysed allelic deletions on chromosome 5 in microdissected human non-small cell lung cancers. Thirty-four primary squamous cell carcinomas, 15 primary adenocarcinomas and five regional lymph node metastases were investigated for loss of heterozygosity (LOH) in chromosomal region 5p15-q21. The sites analysed included the APC tumor suppressor gene at 5q21, five polymorphic microsatellite markers and the putative tumor suppressor locus del-27, that was assigned to chromosomal region 5p13-12 by fluorescence in situ hybridization (FISH) analysis. Allelic deletions encompassed larger genomic regions more often in squamous cell carcinomas than in adenocarcinomas. The del-27 amd APC regions were identified as two distinct regions with the highest LOH frequencies within 5p15-q21. In squamous cell carcinomas LOH frequencies were 73% at the del-27 and 70% at the APC locus. In adenocarcinomas LOH at the del-27 and APC loci occurred in 38% of the informative cases. Allelic deletion of the APC gene and at the del-27 locus was also detected in the metastases. The results suggest involvement of at least two tumor suppressor genes on chromosome 5 in lung tumorigenesis.

Entities:  

Mesh:

Year:  1996        PMID: 8552404

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Microbeam MOMeNT: non-contact laser microdissection of membrane-mounted native tissue.

Authors:  M Böhm; I Wieland; K Schütze; H Rübben
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

2.  Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma.

Authors:  P Mendes-da-Silva; A Moreira; J Duro-da-Costa; D Matias; C Monteiro
Journal:  Mol Pathol       Date:  2000-08

3.  Human and mouse homologs of Schizosaccharomyces pombe rad1(+) and Saccharomyces cerevisiae RAD17: linkage to checkpoint control and mammalian meiosis.

Authors:  R Freire; J R Murguía; M Tarsounas; N F Lowndes; P B Moens; S P Jackson
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

4.  The single-strand DNA binding activity of human PC4 prevents mutagenesis and killing by oxidative DNA damage.

Authors:  Jen-Yeu Wang; Altaf Hossain Sarker; Priscilla K Cooper; Michael R Volkert
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

5.  Coactivator PC4 mediates AP-2 transcriptional activity and suppresses ras-induced transformation dependent on AP-2 transcriptional interference.

Authors:  P Kannan; M A Tainsky
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

6.  The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers.

Authors:  Enrique Zudaire; Natalia Cuesta; Vundavalli Murty; Karen Woodson; Lisa Adams; Nieves Gonzalez; Alfredo Martínez; Gopeshwar Narayan; Ilan Kirsch; Wilbur Franklin; Fred Hirsch; Michael Birrer; Frank Cuttitta
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  The aryl hydrocarbon receptor repressor - More than a simple feedback inhibitor of AhR signaling: Clues for its role in inflammation and cancer.

Authors:  Christoph F A Vogel; Thomas Haarmann-Stemmann
Journal:  Curr Opin Toxicol       Date:  2017-03-01

8.  Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer.

Authors:  A Achille; A Baron; G Zamboni; C Di Pace; S Orlandini; A Scarpa
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

9.  Spaceflight alters the gene expression profile of cervical cancer cells.

Authors:  Zhi-Jie Zhang; Yong-Qing Tong; Jia-Jia Wang; Cheng Yang; Guo-Hua Zhou; Yue-Hui Li; Ping-Li Xie; Jin-Yue Hu; Guan-Cheng Li
Journal:  Chin J Cancer       Date:  2011-11-18

10.  Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis.

Authors:  Miriam M Küster; Marc A Schneider; Antje M Richter; Sarah Richtmann; Hauke Winter; Mark Kriegsmann; Soni S Pullamsetti; Thorsten Stiewe; Rajkumar Savai; Thomas Muley; Reinhard H Dammann
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.